JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule
Brand(s)
Last updated
Summary
Product
JAMP - ESCITALOPRAM 20mg
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Distribution
National
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| JAMP PHARMA CORPORATION | JAMP-Escitalopram | DIN 02429799 | Tablet | ESCITALOPRAM OXALATE 20mg | H232451B |
Issue
The affected lot (JAMP-Escitalopram 20mg) may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers & Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville, QC
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-76800
Get notified
Receive notifications for new and updated recalls and alerts by category.